FDA NDC
Cinryze
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 42227-081
- Proprietary name
- Cinryze
- Nonproprietary name
- HUMAN C1-ESTERASE INHIBITOR
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Strength
- 500 [iU]/5mL
HCPCS J0598 Billable units per 11-digit NDC: 50.
Run it in Rivvi
Which 2027 plans near you dropped or restricted HUMAN C1-ESTERASE INHIBITOR?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.